Table 1.
Baseline characteristics of patients whose provider teams were randomized to the CKD registry or the usual care registry.
| Patient Characteristics | All (N =746( | Usual care Registry (n=461( | CKD Registry (n=285) | p - value |
|---|---|---|---|---|
| Age | 56.7 (12.1) | 57.6 (11.6) | 55.3 (12.7) | 0.01 |
| Female Sex* | 377 (52.7) | 230 (51.2) | 147 (55.1) | 0.3 |
| Race/ethnicity | <0.01 | |||
| White | 56 (7.5) | 47 (10.2) | 9 (3.2) | |
| Black | 267 (35.8) | 154 (33.4) | 113 (39.7) | |
| Hispanic | 183 (24.5) | 107 (23.2) | 76 (26.7) | |
| Asian | 182 (24.4) | 126 (27.3) | 56 (19.7) | |
| Other | 58 (7.8) | 27 (5.8) | 31 (10.9) | |
| Non-English language** | 165 (27.8) | 111 (31.2) | 54 (22.8) | 0.03 |
| Health insurance*** | 0.6 | |||
| None | 142 (23.5) | 90 (25.2) | 52 (21.1) | |
| Medi-Cal | 291 (48.3) | 174 (48.7) | 117 (47.6) | |
| Medi-Care | 128 (21.2) | 70 (19.6) | 58 (23.6) | |
| Other | 42 (7.0) | 23 (6.4) | 19 (7.7) | |
| CKD | 0.2 | |||
| Stages 1-2 | 310 (41.6) | 182 (39.5) | 128 (44.9) | |
| Stage 3a | 288 (38.6) | 181 (39.2) | 107 (37.5) | |
| Stage 3b | 112 (15.0) | 70 (15.2) | 42 (14.7) | |
| Stage 4 | 36 (4.8) | 28 (6.1) | 8 (2.8) | |
| eGFR, mL/min/1.73 m2 | 65.6 (30.5) | 64.7 (30.4) | 67.9 (30.8) | 0.4 |
| Albuminuria quantification**** | 284 (38.0) | 170 (36.9) | 114 (40.0) | 0.4 |
| Albuminuria at first quantification, mg/g | 421 (951) | 440 (1087) | 394 (703) | 0.6 |
| HbA1c > 6.5% | 143 (19.1) | 89 (19.3) | 54 (19.0) | 0.9 |
| BP > 140/90 mmHg, | 268 (35.9) | 162 (35.1) | 106 (37.2) | 0.6 |
| Systolic BP (mmHg) | 133.6 (20.9) | 133.9 (20.3) | 133.2 (21.9) | 0.7 |
| Diastolic BP (mmHg) | 79.6 (12.7) | 79.6 (11.6) | 79.6 (14.3) | 0.9 |
Values for continuous data given as mean +/− SD; for categorical data as count (column percentage).
*
denominator is 715
**
denominator is 593
***
denominator is 603
****
albuminuria denominator, n=646
CKD = Chronic Kidney Disease; HbA1c = Glycosylated Hemoglobin; BP = Blood Pressure